Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Soluble VCAM-1 / Soluble ICAM-1 Ratio as a Non-invasive Biomarker for Diagnosing Endometriosis - a Prospective Multicenter Validation Study

NCT04294017 is registered in ClinicalTrials.gov with Heinrich Husslein as lead sponsor.

NCT NCT04294017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04294017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Soluble VCAM-1 / Soluble ICAM-1 Ratio as a Non-invasive Biomarker for Diagnosing Endometriosis - a Prospective Multicenter Validation Study
Lead sponsor
Heinrich Husslein
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2017
Completion date
December 31, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis (diagnosis), identification of biomarkers in serum